Next 10 |
2023-08-30 12:02:25 ET More on Globus Medical, NuVasive, etc. NuVasive: 6.6% Spread With Globus Deal Still Not Enough Globus Medical: Slightly Too Pricey Right Now Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy NuVasive: Critical Factors Unc...
2023-08-29 05:54:01 ET Relates stories Goosehead Insurance: Growing Quickly But At An Unappealing Price Still Goosehead Insurance, Inc. ( GSHD ) Q2 2023 Earnings Call Transcript Jackson Financial: Finally Rising From The Ashes Jackson Financial: Selling A...
2023-08-28 20:37:32 ET More on Goosehead Insurance, Jackson Financial Goosehead Insurance: Growing Quickly But At An Unappealing Price Still Jackson Financial: Finally Rising From The Ashes Jackson Financial: Selling Annuities Is Better Than Buying Annuities ...
2023-08-28 17:59:15 ET More on Goosehead Insurance, NuVasive, etc. NuVasive: 6.6% Spread With Globus Deal Still Not Enough Goosehead Insurance: Growing Quickly But At An Unappealing Price Still NuVasive, Inc. ( NUVA ) Q2 2023 Earnings Call Transcript NuVa...
Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600 Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600 PR Newswire NEW YORK , Aug. 28, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following c...
2023-08-28 13:41:10 ET More on NuVasive NuVasive: 6.6% Spread With Globus Deal Still Not Enough NuVasive, Inc. ( NUVA ) Q2 2023 Earnings Call Transcript NuVasive: Critical Factors Unchanged, Reiterate Hold NuVasive/Globus deal spread narrows amid report o...
2023-08-18 17:34:12 ET Summary NuVasive continues to push sideways in lieu of the FTC's decision on its prospective merger with Globus Medical. The deal spread between the offer and market price of both entities remains in situ. The firm's financial and economic characteristic...
2023-08-18 16:47:19 ET More on NuVasive NuVasive, Inc. ( NUVA ) Q2 2023 Earnings Call Transcript NuVasive: Critical Factors Unchanged, Reiterate Hold NuVasive Non-GAAP EPS of $0.56 beats by $0.01, revenue of $317.8M misses by $5.32M Globus Medical rises a...
2023-08-03 11:08:43 ET NUVA fell 3% scheduled to report Q2 results 2.7% More on Nuvasive/Globus Medical Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy NuVasive: Critical Factors Unchanged, Reiterate Hold NuVasive merger with Globus M...
2023-08-02 20:27:05 ET NuVasive, Inc. (NUVA) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ET Company Participants Juliet Cunningham – Vice President-Investor Relations Chris Barry – Chief Executive Officer Matt Harbaugh – Chief Fin...
News, Short Squeeze, Breakout and More Instantly...
Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600 Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600 PR Newswire NEW YORK , Aug. 28, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following c...
NuVasive Announces Second Quarter 2023 Financial Results PR Newswire – U.S. Cervical continues to deliver greater than 20% year-over-year growth– – International net sales grew 6.8% as reported and 9.8% on a constant currency basis– ...
NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results PR Newswire SAN DIEGO , July 24, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disr...